| GC33588-1g |
|
3252-36-6 |
BCDA (5-bromo-4-chloroindoxyl acetate)
|
0 |
C10H7BrClNO2 |
|
|
|
| GC33588-500mg |
|
3252-36-6 |
BCDA (5-bromo-4-chloroindoxyl acetate)
|
0 |
C10H7BrClNO2 |
|
|
|
| GC33588-100mg |
|
3252-36-6 |
BCDA (5-bromo-4-chloroindoxyl acetate)
|
0 |
C10H7BrClNO2 |
|
|
|
| GC33587-1mg |
|
83104-85-2 |
Quin-2AM (Quin-2 acetoxymethyl ester)
|
0 |
C38H43N3O18 |
|
|
|
| GC33586-10mg |
|
247171-44-4 |
Tyrosine Protein Kinase JAK 2 Phospho-Tyr8, 9
|
0 |
C88H138N20O34P2 |
|
|
|
| GC33586-5mg |
|
247171-44-4 |
Tyrosine Protein Kinase JAK 2 Phospho-Tyr8, 9
|
0 |
C88H138N20O34P2 |
|
|
|
| GC33586-1mg |
|
247171-44-4 |
Tyrosine Protein Kinase JAK 2 Phospho-Tyr8, 9
|
0 |
C88H138N20O34P2 |
|
|
|
| GC33585-10mg |
|
265669-37-2 |
|
0 |
C49H76N12O15 |
|
|
|
| GC33585-5mg |
|
265669-37-2 |
|
0 |
C49H76N12O15 |
|
|
|
| GC33585-1mg |
|
265669-37-2 |
|
0 |
C49H76N12O15 |
|
|
|
| GC33582-1g |
|
635-78-9 |
|
0 |
C12H7NO3 |
|
|
|
| GC33582-500mg |
|
635-78-9 |
|
0 |
C12H7NO3 |
|
|
|
| GC33582-250mg |
|
635-78-9 |
|
0 |
C12H7NO3 |
|
|
|
| GC33582-100mg |
|
635-78-9 |
|
0 |
C12H7NO3 |
|
|
|
| GC33582-10mM(1mL in DMSO) |
|
635-78-9 |
|
0 |
C12H7NO3 |
|
|
|
| GC33581-10mg |
|
124454-83-7 |
Nucleoprotein 118-126 (NP(118-126))
|
0 |
C43H69N13O13S |
|
|
|
| GC33581-5mg |
|
124454-83-7 |
Nucleoprotein 118-126 (NP(118-126))
|
0 |
C43H69N13O13S |
|
|
|
| GC33581-1mg |
|
124454-83-7 |
Nucleoprotein 118-126 (NP(118-126))
|
0 |
C43H69N13O13S |
|
|
|
| GC33580-10mg |
|
73870-35-6 |
Foresaconitine (Vilmorrianine C)
|
0 |
C35H49NO9 |
|
|
|
| GC33580-5mg |
|
73870-35-6 |
Foresaconitine (Vilmorrianine C)
|
0 |
C35H49NO9 |
|
|
|
